Nu-Med Plus (NUMD) Long-Term Deferred Tax (2013 - 2022)

Nu-Med Plus (NUMD) has 7 years of Long-Term Deferred Tax data on file, last reported at $2.1 million in Q4 2022.

• For the quarter ending Q4 2022, Long-Term Deferred Tax changed 0.46% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2022 stood at $2.1 million (changed 0.46% YoY), and the FY2022 full-year result was $2.1 million, changed 0.46% from the prior year.
• Long-Term Deferred Tax steadied at $2.1 million in Q4 2022, from $2.1 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.1 million in Q4 2021 to a low of $1.9 million in Q4 2020.
• A 4-year average of $2.0 million and a median of $2.0 million in 2018 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax surged 235.58% in 2018 and retreated 0.46% in 2022, its largest moves.
• Tracing NUMD's Long-Term Deferred Tax over 4 years: stood at $1.9 million in 2018, then retreated by 0.86% to $1.9 million in 2020, then gained by 8.39% to $2.1 million in 2021, then declined by 0.46% to $2.1 million in 2022.
• Business Quant data shows NUMD's Long-Term Deferred Tax at $2.1 million in Q4 2022, $2.1 million in Q4 2021, and $1.9 million in Q4 2020.